# Blog

**URL:** https://community.opentargets.org/c/blog-comments/37.md

[Latest](https://community.opentargets.org/latest.md) · [Categories](https://community.opentargets.org/categories.md) · [Tags](https://community.opentargets.org/tags.md)

---

## [About the Blog category](https://community.opentargets.org/t/about-the-blog-category/127)

<div class="topic-metadata">

**Author:** [@hcornu](https://community.opentargets.org/u/hcornu)\
**Replies:** 0

</div>

---

## [How Ana Cvejic built an immune atlas of lung cancer](https://community.opentargets.org/t/how-ana-cvejic-built-an-immune-atlas-of-lung-cancer/1432)

<div class="topic-metadata">

**Author:** [@community\_manager](https://community.opentargets.org/u/community_manager)\
**Replies:** 5\
**Last updated:** [15 October 2025 19:11 UTC](https://community.opentargets.org/t/how-ana-cvejic-built-an-immune-atlas-of-lung-cancer/1432 "2025-10-15T19:11:24Z")

</div>

Lung cancer is the deadliest form of cancer worldwide. Non-small cell lung cancer (NSCLC) is the most common form, making up 85% of cases. In a paper published today in Nature Communications, Open Targets researchers and…

---

## [Open Targets Platform 21.06 has been released!](https://community.opentargets.org/t/open-targets-platform-21-06-has-been-released/242)

<div class="topic-metadata">

**Author:** [@community\_manager](https://community.opentargets.org/u/community_manager)\
**Replies:** 1\
**Last updated:** [1 July 2021 16:35 UTC](https://community.opentargets.org/t/open-targets-platform-21-06-has-been-released/242 "2021-07-01T16:35:42Z")

</div>

The latest release of the Open Targets Platform — 21.06 — is now available at platform.opentargets.org. This is a companion discussion topic for the original entry at https://blog.opentargets.org/open-targets-platform-…